Answers are grounded in this paper and cite their sources.
Background/Objectives: Long-term adherence to colchicine therapy is essential for effective management of familial Mediterranean fever (FMF). This study aimed to assess colchicine adherence and examine associated sociodemographic and clinical factors among adults with FMF in Türkiye. Methods: This descriptive, cross-sectional, and correlational study was conducted online between May and September 2025 and reported in accordance with the Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) guidelines. A total of 312 adults with FMF who had received colchicine treatment for at least one year were recruited across Türkiye using non-probability convenience sampling through the social media accounts of a patient association. Data were collected using a Participant Information Form and the adult version of the Medication Adherence Scale in FMF Patients (MASIF). Descriptive statistics and exploratory group comparisons were performed. Results: The mean MASIF total score was 63.38 ± 7.77, and 67.3% of participants were classified as having good medication adherence, whereas 32.7% demonstrated poor adherence. MASIF total scores differed significantly according to age, marital status, duration of FMF, duration of colchicine use, living arrangements, and regular follow-up attendance. Conclusions: Approximately one-third of participants demonstrated poor adherence to colchicine treatment, highlighting the importance of routine adherence assessment, individualized patient education, and continuity of follow-up care. Further longitudinal and multicenter studies are needed to clarify factors associated with colchicine adherence and inform targeted nursing interventions.
No takes yet. Share an insight, caveat, or question.
Alabsi et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: